These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28534703)

  • 1. Chlorhexidine and silver sulfadiazine coating on central venous catheters is not sufficient for protection against catheter-related infection: Simulation-based laboratory research with clinical validation.
    Choi YJ; Lim JK; Park JJ; Huh H; Kim DJ; Gong CH; Yoon SZ
    J Int Med Res; 2017 Jun; 45(3):1042-1053. PubMed ID: 28534703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study.
    Cui YH; Choi YJ; Kim EH; Yu JH; Seong HY; Choi SU; Yoon SZ; Huh H
    Medicine (Baltimore); 2020 Sep; 99(39):e22218. PubMed ID: 32991414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
    Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New choices for central venous catheters: potential financial implications.
    Shorr AF; Humphreys CW; Helman DL
    Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central venous catheterization: a prospective, randomized, double-blind study.
    Mer M; Duse AG; Galpin JS; Richards GA
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):19-26. PubMed ID: 18593746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
    Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis.
    Casey AL; Mermel LA; Nightingale P; Elliott TS
    Lancet Infect Dis; 2008 Dec; 8(12):763-76. PubMed ID: 19022192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters.
    Hanna H; Bahna P; Reitzel R; Dvorak T; Chaiban G; Hachem R; Raad I
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3283-8. PubMed ID: 17005806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
    Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
    JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.
    Heard SO; Wagle M; Vijayakumar E; McLean S; Brueggemann A; Napolitano LM; Edwards LP; O'Connell FM; Puyana JC; Doern GV
    Arch Intern Med; 1998 Jan; 158(1):81-7. PubMed ID: 9437382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
    Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB
    J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimicrobial effectiveness of chlorhexidine and chlorhexidine-silver sulfadiazine-impregnated central venous catheters against the emerging fungal pathogen Candida auris.
    Gupta N; Haughton S; Kemper S; Koehler M; Antoon R; Edwards CG; Bardin A
    Am J Infect Control; 2024 Nov; 52(11):1283-1288. PubMed ID: 38944155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.
    Lorente L; Lecuona M; Jiménez A; Santacreu R; Raja L; Gonzalez O; Mora ML
    Am J Infect Control; 2014 Mar; 42(3):321-4. PubMed ID: 24581021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.
    Walder B; Pittet D; Tramèr MR
    Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
    Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
    Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.